Global Patent Index - EP 1165116 A1

EP 1165116 A1 20020102 - USE OF SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR FOR TREATING HEART FAILURE

Title (en)

USE OF SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR FOR TREATING HEART FAILURE

Title (de)

VERWENDUNG VON LÖSLICHE TUMOR NECROSIS FAKTOR REZEPTOR BEI DER BEHANDLUNG DES HERZVERSAGENS

Title (fr)

UTILISATION D'UN RECEPTEUR DU FACTEUR DE NECROSE TUMORALE SOLUBLE DANS LE TRAITEMENT DE L'INSUFFISANCE CARDIAQUE

Publication

EP 1165116 A1 20020102 (EN)

Application

EP 00918469 A 20000328

Priority

  • US 0008161 W 20000328
  • US 12758899 P 19990402

Abstract (en)

[origin: WO0059530A1] The invention provides methods of treating chronic heart failure in a human patient by repeatedly administering TNFR:Fc for a time sufficient to induce an improvement in an indicator of chronic heart failure.

IPC 1-7

A61K 38/17; A61K 38/19

IPC 8 full level

A61K 38/17 (2006.01); A61K 38/19 (2006.01)

CPC (source: EP)

A61K 38/191 (2013.01)

Citation (search report)

See references of WO 0059530A1

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

DOCDB simple family (publication)

WO 0059530 A1 20001012; AU 3927100 A 20001023; AU 763575 B2 20030724; CA 2365824 A1 20001012; EP 1165116 A1 20020102

DOCDB simple family (application)

US 0008161 W 20000328; AU 3927100 A 20000328; CA 2365824 A 20000328; EP 00918469 A 20000328